Personalized DC injection(Zhongsheng Kangyuan Biotechnology)

个性化树突状细胞注射液（中生康元生物）

Report date: 2026/01/22 20:00:10

Base Information

Drug NamePersonalized DC injection(Zhongsheng Kangyuan Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursLiver NeoplasmsGlioblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhongsheng Kangyuan Biotechnology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLiver NeoplasmsGlioblastoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A